Solos Attends ABSICON 2019
The original release is unavailable here.
CYduct Diagnostics Inc. on 6ix
Earlier from CYduct Diagnostics
- Solos Endoscopy Eliminates Its Derivative Liability
- Solos Reports 1st Qtr Increases
- Solos Endoscopy Further Reduces its Outstanding Convertible Preferred Stock
- Solos Continues Restructuring Outstanding Preferred Stock
- Solos' Restructures Outstanding Preferred Stock
Later from CYduct Diagnostics
- Solos Introduces MammoView at ABSICON
- Solos Endoscopy, Inc. Appoints Distributor to Expand Their MammoView Sales Into India
- SNDY to Focus on Breast Cancer Market
- Solos Endoscopy, Inc. Will Look to Become a Women’s Healthcare Focused Company
- Solos Endoscopy, Inc. Reports Improved Results for Fiscal Year 2019
Follow CYduct Diagnostics into a list and get an email when it puts out news.
Follow CYduct Diagnostics